Insulin signaling in health and disease
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms of cellular insulin action have been the focus of much investigation since the discovery of the hormone 100 years ago. Insulin action is impaired in metabolic syndrome, a condition known as insulin resistance. The actions of the hormone are initiated by binding to its receptor on the surface of target cells. The receptor is an α2β2 heterodimer that binds to insulin with high affinity, resulting in the activation of its tyrosine kinase activity. Once activated, the receptor can phosphorylate a number of intracellular substrates that initiate discrete signaling pathways. The tyrosine phosphorylation of some substrates activates phosphatidylinositol-3-kinase (PI3K), which produces polyphosphoinositides that interact with protein kinases, leading to activation of the kinase Akt. Phosphorylation of Shc leads to activation of the Ras/MAP kinase pathway. Phosphorylation of SH2B2 and of Cbl initiates activation of G proteins such as TC10. Activation of Akt and other protein kinases produces phosphorylation of a variety of substrates, including transcription factors, GTPase-activating proteins, and other kinases that control key metabolic events. Among the cellular processes controlled by insulin are vesicle trafficking, activities of metabolic enzymes, transcriptional factors, and degradation of insulin itself. Together these complex processes are coordinated to ensure glucose homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 1×
“Ser473 appears to be phosphorylated mainly by the rapamycin-insensitive mTOR complex mTORC2 (80).”
BackgroundAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 7×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“The tyrosine residues phosphorylated in each substrate occur in specific sequence motifs; once phosphorylated, they serve as docking sites for intracellular molecules containing SH2 (Src homology 2) domains (1).”
BackgroundSelf-citationInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 6×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialCellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · cited 1×
“In part, variability may reflect the presence of three Akt isoforms (88).”
BackgroundDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 2×
“Hirosumi J, et al. A central role for JNK in obesity and insulin resistance.”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826 · cited 1×
“PI-(3,4,5)P3 recruits the serine/threonine kinase phosphoinositide-dependent kinase 1 (PDK1) to the plasma membrane through its PH domain and phosphorylates Thr308 on Akt (78, 79).”
BackgroundCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · cited 5×
“Other AGC kinases activated downstream of PI3K include the protein kinase C (PKC) family, particularly PKC-ζ.”
BackgroundInfluential
Research works printed but not linked: 4
- Kido, 2001, Clinical review 125: The insulin receptor and its cellular targets, J Clin Endocrinol Metab, 86, 972
- O-Sullivan, 2015, FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization, Nat Commun, 6
- 10.1172/JCI23096 · doi:10.1172/jci23096 · Paper page
- 10.1210/jcem.82.6.3979 · doi:10.1210/jcem.82.6.3979 · Paper page
Cited by
Exosomes as mediators of intercellular crosstalk in metabolism
Isaac, R., Reis, F. C. G., Ying, W., & Olefsky, J. M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.006 · Cited by 820
Mechanisms of Oxidative Stress in Metabolic Syndrome
Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097898 · Cited by 717
Role of Insulin in Health and Disease: An Update
Rahman, M. S., Hossain, K. S., Das, S., Kundu, S., Adegoke, E. O., Rahman, M. A., Hannan, M. A., Uddin, M. J., & Pang, M.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126403 · Cited by 472
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Insulin resistance and cardiovascular disease
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023) · Journal of International Medical Research · doi:10.1177/03000605231164548 · Cited by 385
Insulin: The master regulator of glucose metabolism
Norton, L., Shannon, C., Gastaldelli, A., & DeFronzo, R. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155142 · Cited by 330
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes
Hogrebe, N. J., Ishahak, M., & Millman, J. R. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.04.002 · Cited by 210
FOXO transcription factors as therapeutic targets in human diseases
Orea-Soufi, A., Paik, J., Bragança, J., Donlon, T. A., Willcox, B. J., & Link, W. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.09.010 · Cited by 177
Tong, C., Wu, Y., Zhang, L., & Yu, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1091147 · Cited by 157
“AKT inhibits apoptosis either directly by inhibiting pro-apoptotic proteins (BAD) or by inhibiting pro-apoptotic signals generated by FOXO1, of which the downstream signals are p53 for the former and FASL and BIM for the latter (40) (Figure 4).”
BackgroundHuang, D., Zhang, Y., Long, J., Yang, X., Li, B., Yang, Z., Wu, B., Si, R., Zhao, W., Peng, C. Y., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155937 · Cited by 175
Xiong, Y., Knoedler, S. A., Alfertshofer, M. G., Kim, B., Jiang, D., Liu, G., Rinkevich, Y., & Mi, B. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07583-3 · Cited by 188
Oxidative stress: The nexus of obesity and cognitive dysfunction in diabetes
Li, H., Ren, J. L., Li, Y., Wu, Q., & Wei, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1134025 · Cited by 202
“Insulin receptor substrates (IRSs) work as scaffold protein driving activation of two primary insulin signaling pathways: 1) PI3K/PDK1/Akt pathway; And 2) MAPK pathway (85).”
BackgroundInsulin signaling and its application
Thi Kim Chung, L. E., Dao, X. D., Nguyen, D. V., Luu, D. H., Bui, T. M. H., Le, T. H., Nguyen, H. T., Le, N. T., Hosaka, T., & Nguyen, T. T. T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1226655 · Cited by 153
Exosome-Mediated Impact on Systemic Metabolism
Cunha e Rocha, K., Ying, W., & Olefsky, J. M. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042222-024535 · Cited by 101
Diabetic Wound Repair: From Mechanism to Therapeutic Opportunities
Wang, R., Gu, S., Kim, Y. H., Lee, A., Lin, H., & Jiang, D. (2025) · MedComm · doi:10.1002/mco2.70406 · Cited by 140
Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IRβ
Zhou, Q., Sun, W.-W., Chen, J.-C., Zhang, H.-L., Liu, J., Lin, Y., Lin, P., Wu, B., An, Y., Huang, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32000-0 · Cited by 119
Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Su, J., Luo, Y., Hu, S., Tang, L., & Ouyang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713381 · Cited by 127
“When PDK1 translocates to the membrane, PIP3 then binds to the PH structural domain of AKT, causing AKT to translocate to the membrane and a conformational change in AKT, thereby making the Thr site of AKT more susceptible to phosphorylation by PDK1 [56,59].”
BackgroundTruong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
Akt: A Potential Drug Target for Metabolic Syndrome
Miao, R., Fang, X., Wei, J., Wu, H., Wang, X., & Tian, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.822333 · Cited by 100
“The PI3K/Akt pathway is one of the key insulinrelated pathways for regulating glucose and lipid metabolism (Saltiel, 2021).”
BackgroundInfluentialSarcopenia, frailty and type 2 diabetes mellitus (Review)
Nishikawa, H., Fukunishi, S., Asai, A., Yokohama, K., Ohama, H., Nishiguchi, S., & Higuchi, K. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12494 · Cited by 84
Metabolic hormones are integral regulators of female reproductive health and function
Athar, F., Karmani, M., & Templeman, N. M. (2024) · Bioscience Reports · doi:10.1042/bsr20231916 · Cited by 91
Crosstalk Between the Neuroendocrine System and Bone Homeostasis
Zhao, Y., Peng, X., Wang, Q., Zhang, Z., Wang, L., Xu, Y., Yang, H., Bai, J., & Geng, D. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad025 · Cited by 78
Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond
Yu, W., Xie, D., Yamamoto, T., Koyama, H., & Cheng, J. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09787-4 · Cited by 70
Changes in Cells Associated with Insulin Resistance
Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042397 · Cited by 88
“Then, activated ERKs are translocated to the nucleus, where they cause phosphorylation and transcriptional activation by transcriptional factors, such as ELK1, promoting cell division, protein synthesis and cell growth [3,6,36].”
BackgroundBiology of Activating Transcription Factor 4 (ATF4) and Its Role in Skeletal Muscle Atrophy
Ebert, S. M., Rasmussen, B. B., Judge, A. R., Judge, S. M., Larsson, L., Wek, R. C., Anthony, T. G., Marcotte, G. R., Miller, M. J., Yorek, M. A., et al. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab440 · Cited by 68
Hormonal regulation of metabolism—recent lessons learned from insulin and estrogen
Tao, Z., & Cheng, Z. (2023) · Clinical Science · doi:10.1042/cs20210519 · Cited by 72
The Effect of Omega-3 Fatty Acids on Insulin Resistance
Sinha, S., Haque, M., Lugova, H., & Kumar, S. (2023) · Life · doi:10.3390/life13061322 · Cited by 74
“In order to mediate insulin-induced absorption of glucose and decrease gluconeogenesis, the PI3K-AKT path is acknowledged for playing a crucial role [29] (Figure 2).”
BackgroundPrimordial Drivers of Diabetes Heart Disease: Comprehensive Insights into Insulin Resistance
Fan, Y., Yan, Z., Li, T., Li, A., Fan, X., Qi, Z., & Zhang, J. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0110 · Cited by 67
Lee, S., & Yoon, K. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0163 · Cited by 68
“These findings were the cornerstone of insulinrelated studies and were followed by a tremendous amount of research on insulin signaling and insulin resistance [34,35].”
BackgroundAdipocyte CAMK2 deficiency improves obesity-associated glucose intolerance
Dai, W., Choubey, M., Patel, S., Singer, H. A., & Özcan, L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101300 · Cited by 50
The IQGAP scaffolds: Critical nodes bridging receptor activation to cellular signaling
Thines, L., Roushar, F. J., Hedman, A. C., & Sacks, D. B. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202205062 · Cited by 53
“Activated IR recruits and phosphorylates insulin receptor substrate-1 (IRS-1), which recruits signaling proteins, including PI3K, which activates Akt to control GLUT4-mediated glucose uptake (Saltiel, 2021).”
BackgroundDu, R., Wu, N., Bai, Y., Tang, L., & Li, L. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03386-8 · Cited by 52
Shao, Z., Tian, Y., Liu, S., Chu, X., & Mao, W. (2023) · Marine Drugs · doi:10.3390/md21050270 · Cited by 43
“Insulin secretion deficiency and insulin resistance are typical features of T2DM, which result in hyperglycemia and impaired glucose metabolism [31].”
BackgroundArner, P., Viguerie, N., Massier, L., Rydén, M., Astrup, A. V., Blaak, E. E., Langin, D., & Andersson, D. P. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01501-x · Cited by 55
Gu, L., Zhu, Y., Watari, K., Lee, M., Liu, J., Perez, S., Thai, M., Mayfield, J. E., Zhang, B., Rocha, K. C. E., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.021 · Cited by 46
Self-citationShraim, B. A., Moursi, M. O., Benter, I. F., Habib, A. M., & Akhtar, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.701390 · Cited by 47
“Insulin resistance is strongly associated with visceral obesity and the resulting chronic lowgrade inflammation as well as increased ectopic fat deposition (Saltiel, 2021; Tsatsoulis, et al., 2013).”
BackgroundPal, S., Sahu, A., Verma, R., & Haldar, C. (2023) · Journal of Pineal Research · doi:10.1111/jpi.12869 · Cited by 46
Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte
Habegger, K. M. (2022) · Diabetes · doi:10.2337/dbi22-0002 · Cited by 44
Endocrine disorders associated with obesity
Park, H. K., & Ahima, R. S. (2023) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2023.102394 · Cited by 38
VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway
Li, Y., Li, W., Zhu, X., Xu, N., Meng, Q., Jiang, W., Zhang, L., Yang, M., Xu, F., & Li, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05621-w · Cited by 42
Chen, H., Li, J., Zhang, Y., Zhang, W., Li, X., Tang, H., Liu, Y., Li, T., He, H., Du, B., et al. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113201 · Cited by 43
Park, S., Kim, C., & Wu, X. (2022) · Diagnostics · doi:10.3390/diagnostics12010212 · Cited by 45
Nurkolis, F., Harbuwono, D. S., Taslim, N. A., Soegondo, S., Suastika, K., Sparringa, R. A., Mustika, A., Syam, A. F., Santini, A., Holly, J. M. P., et al. (2025) · Discover Food · doi:10.1007/s44187-025-00422-6 · Cited by 49
Shen, H., Xu, X. L., Fu, Z., Xu, C., & Wang, Y. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155164 · Cited by 39
Insulin signaling in development
Suzawa, M., & Bland, M. L. (2023) · Development · doi:10.1242/dev.201599 · Cited by 36
Phase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomes
Gao, X., Rao, X., Cong, X., Sheng, Z., Sun, Y.-T., Xu, S.-B., Wang, J.-F., Liang, Y.-H., Lu, L.-R., Ouyang, H.-W., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00426-x · Cited by 28
de Deus, I. J., Martins-Silva, A. F., Fagundes, M. M. D. A., Paula-Gomes, S., Silva, F. G. D. E., da Cruz, L. L., de Abreu, A. R. R., & de Queiroz, K. B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1188829 · Cited by 46
“The existence of a PDK2 has been postulated, and evidence have revealed that the mTOR complex 2 (mTORC2) might be the PDK2 for AKT/PKB signaling (Figure 1) (Abdelmageed et al., 2021; Mata-Torres et al., 2021) [For further information see (Saltiel, 2021)].”
BackgroundNeuronal glucose sensing mechanisms and circuits in the control of insulin and glucagon secretion
Thorens, B. (2024) · Physiological Reviews · doi:10.1152/physrev.00038.2023 · Cited by 39
The Vagal Nerve, Inflammation, and Diabetes—A Holy Triangle
Sorski, L., & Gidron, Y. (2023) · Cells · doi:10.3390/cells12121632 · Cited by 38
“Inflammation, oxidative stress and protein kinase C (PKC) activation, are known to trigger a decreased activity of insulin receptor substrate 1 (IRS1) through increased phosphorylation of its serine/threonine and reduced phosphorylation of tyrosine, all of which were found as compromising the signaling of insulin [11].”
BackgroundThe insulin signalling network
Burchfield, J. G., Díaz‐Vegas, A., & James, D. E. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01349-z · Cited by 47
Mir, R., Jeelani, M., Alharthi, M. H., Rizvi, S. F., Sohail, S. K., Wani, J. I., Sabah, Z. U., BinAfif, W. F., Nandi, P. S., Alshahrani, A. M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062770 · Cited by 53
“Insulin and IGF-1 primarily bind to their respective receptors, although both ligands can also interact with the alternative receptor, albeit with diminished affinity [41].”
Insulin action and resistance are dependent on a GSK3β-FBXW7-ERRα transcriptional axis
Xia, H., Scholtes, C., Dufour, C. R., Ouellet, C., Ghahremani, M., & Giguère, V. (2022) · Nature Communications · doi:10.1038/s41467-022-29722-6 · Cited by 34
Molecular inhibition of RAS signalling to target ageing and age-related health
Laskovs, M., Partridge, L., & Slack, C. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049627 · Cited by 41
“The oncogenic RAS small GTPase is a well-known mediator of IIS in mammals that is activated when the insulin/IGF-1 RTK is stimulated (Saltiel, 2021).”
BackgroundInsulin-Responsive Transcription Factors
Thiel, G., Guethlein, L. A., & Rößler, O. G. (2021) · Biomolecules · doi:10.3390/biom11121886 · Cited by 33
Spatiotemporal regulation of insulin signaling by liquid–liquid phase separation
Zhou, K., Chen, Q., Chen, J., Liang, D., Feng, W., Liu, M., Wang, Q., Wang, R., Ouyang, Q., Quan, C., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00430-1 · Cited by 38
Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments
Kuretu, A., Arineitwe, C., Mothibe, M. E., Ngubane, P. S., Khathi, A., & Sibiya, N. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1123928 · Cited by 33
“ATP and other mitochondrial factors accomplish the coupling of glucose metabolism to insulin secretion in the pancreatic b cell (8, 9, 19).”
BackgroundInfluentialMechanism of Anti-Diabetic Activity from Sweet Potato (Ipomoea batatas): A Systematic Review
Arisanti, C. I. S., Wirasuta, I. M. A. G., Musfiroh, I., Ikram, E. H. K., & Muchtaridi, M. (2023) · Foods · doi:10.3390/foods12142810 · Cited by 42
Research progress on drugs for diabetes based on insulin receptor/insulin receptor substrate
Su, J., Tang, L., Luo, Y., Xu, J., & Ouyang, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115830 · Cited by 33
Managing Diabetes with Hydrogel Drug Delivery
Xiang, Y., Su, B., Liu, D., & Webber, M. J. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300127 · Cited by 32
Insulin resistance in cancer risk and prognosis
Jacobo-Tovar, E., Medel-Sánchez, A., Durán-Castillo, C., & Guardado‐Mendoza, R. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.06.006 · Cited by 36
Plasma triacylglycerols are biomarkers of β-cell function in mice and humans
Sánchez-Archidona, A. R., Cruciani‐Guglielmacci, C., Roujeau, C., Wigger, L., Lallement, J., Denom, J., Barovic, M., Kassis, N., Mehl, F., Weitz, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101355 · Cited by 41
Adipose tissue metabolic changes in chronic kidney disease
Serrano, E., Shenoy, P., & Cantarin, M. P. M. (2023) · Immunometabolism · doi:10.1097/in9.0000000000000023 · Cited by 35
“Uremic serum promotes human adipocyte lipolysis [25], and rodent models with CKD have ectopic lipid distribution [29] and suppressed IRS-1-associated phosphoinositide 3-kinase (PI3-K) activity in muscle [65], all processes that can result in the development of IR [66].”
BackgroundWu, L., Wu, X., Hu, H., & Wan, Q. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03684-1 · Cited by 30
Role of transcription factor FOXM1 in diabetes and its complications (Review)
Zhao, B., Li, M., Su, Y., Shan, S., Qian, W., Zhu, D., Liu, X., & Zhang, Z. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5304 · Cited by 31
Hateley, C., Olona, A., Halliday, L. J., Edin, M. L., Ko, J., Forlano, R., Terra, X., Lih, F. B., Beltrán‐Debón, R., Manousou, P., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105127 · Cited by 30
“3,6,7 MASLD affects up to 96% of patients with obesity, though only a proportion of these patients will develop steatohepatitis (7 – 35”
Insulin resistance and cancer: molecular links and clinical perspectives
Caturano, A., Erul, E., Nilo, R., Nilo, D., Russo, V., Rinaldi, L., Acierno, C., Gemelli, M. T., Ricotta, R., Sasso, F. C., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05245-8 · Cited by 30
“In IR, defects in the insulin receptor or its downstream signaling components diminish the efficacy of insulin signaling [70].”
InfluentialGlycemic Control and Bone in Diabetes
Weber, D. R., Long, F., Zemel, B. S., & Kindler, J. M. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00747-6 · Cited by 30
Revising Endosomal Trafficking under Insulin Receptor Activation
Iraburu, M. J., Garner, T., & Montiel‐Duarte, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136978 · Cited by 25
Lin, L., Zeng, L., Liu, A., Yuan, D., Peng, Y., Zhang, S., Li, Y., Chen, J., Xiao, W., & Gong, Z. (2021) · Nutrients · doi:10.3390/nu13114120 · Cited by 28
A precision medicine approach to metabolic therapy for breast cancer in mice
Akingbesote, N. D., Norman, A. D., Zhu, W., Halberstam, A. A., Zhang, X., Foldi, J., Lustberg, M. B., & Perry, R. J. (2022) · Communications Biology · doi:10.1038/s42003-022-03422-9 · Cited by 26
Zhang, N., Zhang, W., Guo, X., Liu, J., Li, S., Zhang, H., & Fan, B. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1072044 · Cited by 28
“Activating hepatic IR and its downstream signaling molecules suppresses glucose uptake and glycogen synthesis on the liver (30).”
BackgroundFrom diabetic hyperglycemia to cerebrovascular Damage: A narrative review
Machado, R. S., Mathias, K., Joaquim, L. D. S., de Quadros, R. W., Petronilho, F. C., & Rezin, G. T. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148611 · Cited by 26
Panda, S. P., Kesharwani, A., Singh, G. D., Prasanth, D., Vatchavai, B. R., Kumari, P. V. K., Panda, S. K., & Mallick, S. P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102086 · Cited by 26
Patra, D., Ramprasad, P., Sharma, S., Dey, U., Kumar, V., Singh, S., Dasgupta, S., Kumar, A. A., Tikoo, K., & Pal, D. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107328 · Cited by 33
“The 3T3L1 adipocytes transfected with miR-210-3p mimic exhibited reduced expression and translocation of GLUT4 , an essential molecule within the insulin signaling pathway (40), suggesting a possible direct targeting of GLUT4 by miR-210-3p .”
Experimental cell models of insulin resistance: overview and appraisal
Yang, Y., Wang, T., Xie, H.-A., Hu, P. P., & Pan, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1469565 · Cited by 33
Insulin Resistance Is a Modifying Factor for Parkinson's Disease
Žagare, A., Hemedan, A. A., Serra-Almeida, C., Frangenberg, D., Gomez‐Giro, G., Antony, P. M. A., Halder, R., Krüger, R., Glaab, E., Ostaszewski, M., et al. (2024) · Movement Disorders · doi:10.1002/mds.30039 · Cited by 28
“12,13 Moreover, several downstream proteins of insulin signaling are shown to be involved in the pathophysiology of PD. 14-16 In particular, forkhead box O (FOXO) transcription factors are linked to metabolic alterations, tyrosine hydroxylase (TH) levels 14 and synuclein alpha ( α Syn) accumulation.”
Xu, F.-Q., & Shi, J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241307404 · Cited by 29
Pathophysiological Link between Insulin Resistance and Adrenal Incidentalomas
Higgs, J. A., Quinn, A. P., Seely, K. D., Richards, Z., Mortensen, S. P., Crandall, C. S., & Brooks, A. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084340 · Cited by 31
Maruta, H., Abe, R., & Yamashita, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094691 · Cited by 23
Sun, M., Zhang, Z., Xie, J., Yu, J., Xiong, S., Xiang, F., Ma, X., Chen, Y., & Lin, L. (2024) · Molecules · doi:10.3390/molecules29204790 · Cited by 32
“In the context of insulin resistance, impaired insulin signaling pathways lead to elevated blood glucose levels, disrupted glucose and lipid metabolism, and the exacerbated progress of diabetes [79].”
BackgroundMechanisms, functions and therapeutic targeting of protein tyrosine phosphatases
Tiganis, T., & Tonks, N. K. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00882-9 · Cited by 29
Calcaterra, V., Verduci, E., Schneider, L. A., Cena, H., SILVESTRI, A. D., Vizzuso, S., Vinci, F., Mameli, C., & Zuccotti, G. (2021) · Children · doi:10.3390/children8060449 · Cited by 26
Role of GALNT2 on Insulin Sensitivity, Lipid Metabolism and Fat Homeostasis
Antonucci, A., Marucci, A., Trischitta, V., & Paola, R. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020929 · Cited by 22
Role of non-coding RNAs on liver metabolism and NAFLD pathogenesis
Qian, G., & Morral, N. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac088 · Cited by 23
Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling
Nagao, H., Cai, W., Brandão, B. B., Albrechtsen, N. J. W., Steger, M., Gattu, A. K., Pan, H., Dreyfuss, J. M., Wunderlich, F. T., Mann, M., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci161472 · Cited by 21
Nagao, H., Jayavelu, A. K., Cai, W., Pan, H., Dreyfuss, J. M., Batista, T. M., Brandão, B. B., Mann, M., & Kahn, C. R. (2023) · Nature Communications · doi:10.1038/s41467-022-35693-5 · Cited by 23
Livingstone, R., Bryant, N. J., Boyle, J. G., Petrie, J. R., & Gould, G. W. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.361 · Cited by 22
Cormerais, Y., Lapp, S. C., Kalafut, K. C., Cissé, M. Y., Shin, J., Stefadu, B., Personnaz, J., Schrötter, S., Freed, J., D’Amore, A., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2025.05.008 · Cited by 28
Regulation of Insulin Clearance by Non-Esterified Fatty Acids
Najjar, S. M., Abdolahipour, R., Ghadieh, H. E., Jahromi, M. S., Najjar, J. A., Abuamreh, B. A. M., Zaidi, S., Kumarasamy, S., & Muturi, H. T. (2022) · Biomedicines · doi:10.3390/biomedicines10081899 · Cited by 22
Jin, C., Gao, B.-B., Zhou, W., Zhao, B., Fang, X., Yang, C.-L., Wang, X., Xia, Q., & Liu, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.972397 · Cited by 20
“In addition, increasing PI3K produced polyphosphoinositides that interacted with protein kinases, leading to activation of the kinase AKT (Saltiel, 2021).”
BackgroundAssociation between type 2 diabetes mellitus and body composition based on MRI fat fraction mapping
An, Q., Zhang, Q., Wang, Y., Zhang, H.-Y., Liu, Y.-H., Zhang, Z., Zhang, M., Lin, L., He, H., Yang, Y., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1332346 · Cited by 24
Shen, X., Yang, H., Yang, Y., Zhu, X., & Sun, Q. (2024) · MedComm · doi:10.1002/mco2.664 · Cited by 23
CircRNA circ_0043533 facilitates cell growth in polycystic ovary syndrome by targeting miR-1179
Chen, A., Jin, R.-Y., Zhou, W., Ye, Y.-J., Lu, J., Ren, Y., & Xuan, F. (2022) · Reproductive Biology · doi:10.1016/j.repbio.2022.100637 · Cited by 19
The Role of Placental Non-Coding RNAs in Adverse Pregnancy Outcomes
Ren, J., Jin, H., & Zhu, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055030 · Cited by 19
“The insulin-PI3K/Akt pathway promotes cellular glucose uptake and regulates cell growth, which is critical for insulin signaling [161].”
BackgroundEndoplasmic reticulum stress mechanisms and exercise intervention in type 2 diabetes mellitus
Chen, Q., Zhao, X., Xu, Z., & Liu, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117122 · Cited by 22
Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance
Pliszka, M., & Szablewski, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031222 · Cited by 19
“The MAPK signaling pathway is associated with cell division, proliferation, differentiation, protein synthesis, and cytoskeletal reorganization [2,35,76,77].”
InfluentialMeng, X., Zhang, Y., Li, Z., Hu, J., Zhang, D., Cao, W., Li, M., Ma, G., Wang, S., Cui, P., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7413 · Cited by 18
Barth, L. A. G., Nebe, M., Kalwa, H., Velluva, A., Kehr, S., Kolbig, F., Prabutzki, P., Kieß, W., Duc, D. L., Garten, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179787 · Cited by 18
Metadata
- Authors
- Saltiel, A. R.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Saltiel, Alan R.
- ORCID
- Saltiel, Alan R.
- Venue
- Journal of Clinical Investigation
- Published
- 2021-01-04
- Volume
- 131
- Issue
- 1
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC7773347
- OpenAlex
- W3119743465
- Cited by
- 446
- References
- 210
- Citations by year
- 2026: 63 · 2025: 113 · 2024: 84 · 2023: 92 · 2022: 72 · 2021: 22
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124496, P30DK063491)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin signaling, insulin resistance, metabolic syndrome, insulin receptor, tyrosine kinase, PI3K/Akt signaling, CBL, TC10, glucose homeostasis, vesicle trafficking, insulin degradation, transcription factors, GTPase-activating protein
- MeSH terms
- Animals, Humans, Insulin, Insulin Resistance, Receptor, Insulin, Phosphatidylinositol 3-Kinases, MAP Kinase Signaling System, Metabolic Syndrome, History, 20th Century, History, 21st Century, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.